SUMMARY PAPERS
Head MG, Fitchett JR, Nageshwaran V, Kumari N, Hayward AC, Atun R. Research investments in global health: a systematic analysis of UK infectious disease research funding and global health metrics, 1997-2013. EBioMedicine. 2016.
Head MG, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, Atun R; UK investments in global infectious disease research 1997-2010: a case study. Lancet Infectious Diseases. 2013.
ORIGINALS ARTICLES, EDITORIALS AND COMMENTARIES
(see further below for correspondence and letters)
Head MG et al. The Allocation of US$ 105 Billion in Global Funding for Infectious Disease Research between 2000 and 2017: An Analysis of Investments from Funders in the G20 Countries (and see interactive visualisation and dashboard of coronavirus R&D funding data
2020
2019
Head MG. Databases for research and development. Emerging Infectious Diseases
2018
Brown RJ. Head MG. Sizing Up Pneumonia Research
Head MG. Brown RJ. Clarke SC. Research investments for UK infectious disease research 1997–2013: A systematic analysis of awards to UK institutions alongside national burden of disease. Journal of Infection.2018. https://doi.org/10.1016/j.jinf.2017.10.006
Zhou CD, Head MG, Marshall DC, et al A systematic analysis of UK cancer research funding by gender of primary investigator BMJ Open
2017
Head MG, Goss S, Gelister Y et al. Inequalities in investments: a systematic analysis of global funding trends for malaria research in sub-Saharan Africa. The Lancet Global Health. 2017.
Maruthappua M,* Head MG,* Zhou C, Gilbert BJ, El-Harasis MA, Raine R, Fitchett JR, Atun R. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis. BMJ Open. 2017.
Fitchett JR, Lichtman A, Soyode DT, Low A, Villar de Onis J, Head MG, Atun R. Ebola research funding: a systematic analysis, 1997–2015. Journal of Global Health. 2016.
Head MG, Brown RJ. The activity of the Research Investments in Global Health study and ways forward within the global funding and policy landscape. BMC Proceedings. 2016.
Fitchett JR, Sharara N, Head MG, Huang F, Atun R. Transparency and availability of data for cancer research. The Lancet. 2016.
Ryu SH, Head MG, Kim BI, Hwang JC, Cho EH. Are we investing wisely? A systematic analysis of nationally funded antimicrobial resistance projects in Korea, 2003-2013. Journal of Global Antimicrobial Resistance. 2016.
Head MG, Lopman BA. Norovirus in 2016 – emesis aplenty but clear signs of progress. Journal of Infectious Diseases. 2016.
Head MG, Fitchett JR, Lichtman AB, Soyode DT, Harris JN, Atun R; Mapping investments and published outputs in Norovirus research: a systematic analysis of US and UK research 1997-2013. Journal of Infectious Diseases. 2016.
2016
Lanza S, Middleton J, Head MG, Bostock J, Nalabanda A, Walker SL, Hewitt K, Cassell JA. Can outbreak research be achieved in a population with impaired capacity? Findings from a study of a scabies outbreak in residential care. The Lancet. 2015.
Head MG, Fitchett JR, Derrick G, Wurie FB, Meldrum J, Kumari N, Beattie B, Counts CJ, Atun R. Comparing research investment to UK institutions and published outputs for tuberculosis, HIV and malaria: a systematic analysis across 1997-2013. Health Research Policy and Systems 2015. This manuscript is part of the WHO R&D Observatory call for evidence
Head MG, Fitchett JR, Clarke SC. Challenges in mapping research investments for treatments against pneumonia. Lancet Infectious Diseases. 2015.
Head MG, Fitchett JR, Cassell JA, Atun R. Investments in sexually transmitted infection research 1997-2013: a systematic analysis of funding awarded to UK institutions. Journal of Global Health. 2015.
Head MG, Fitchett JR, Newell ML, Scott AG, Harris JN, Clarke SC*, Atun R*. Mapping inequities surrounding pneumonia research: a systematic analysis of UK investments and published outputs 1997-2013. EBioMedicine. 2015.
* Joint senior author
Head MG, Walker SL, Nalabanda A, Bostock J, Cassell JC; Scabies research in residential care facilities: the Mental Capacity Act 2005 and issues of consent– a grey area? – Public Health Ethics. 2015.
Head MG, Fitchett JR, Moore DAJ, Atun R; Systematic analysis of funding awarded to institutions in the United Kingdom for infectious disease research, 1997-2010. JRSM Open. 2015.
2015
Fitchett JR, Head MG, Atun R; Investing in sepsis research: systematic analysis of UK public and philanthropic funding 1997–2010. JRSM Open. 2014.
Fitchett JR, Head MG, Cooke MK, Wurie FB, Atun R. Funding Infectious Disease Research: A Systematic Analysis of UK Research Investments by Funders 1997–2010. PLOS One. 2014.
Head MG, Fitchett JR, Cooke GS, Foster GR, Atun R; Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom, 1997-2010 – Journal of Viral Hepatitis. 2014.
Fitchett JR, Head MG, Cooke MK, Wurie FB, Atun R; Funding infectious disease research: A systematic analysis of UK investments by funders 1997-2010. International Journal of Infectious Diseases. 2014.
Fitchett JR, Head MG, Heymann D, Atun R; Investing in emerging infectious diseases: A systematic analysis of UK research. International Journal of Infectious Diseases. 2014.
Head MG, Fitchett JR, Holmes AC, Atun R; Funding healthcare-associated infection research: a systematic analysis of UK research investments, 1997–2010. Journal of Hospital Infection. 2014.
Head MG, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, Lipman ML, Atun R; Investments in respiratory infectious disease research 1997–2010: a systematic analysis of UK funding. BMJ Open 2014.
Fitchett JR, Head MG, Atun R; Infectious disease research investments follow colonial ties: questionable ethics. International Health. January 23, 2014.
Head MG, Fitchett JR, Atun R, May RC; Systematic analysis of funding awarded for mycology research to institutions in the United Kingdom, 1997-2010. BMJ Open 2014.
Head MG, Fitchett JR, Atun R; Investing in antimicrobial resistance research. British Journal of Hospital Medicine. 2014.
Head MG, Fitchett JR, Atun R; Systematic analysis of funding awarded for norovirus research to institutions in the United Kingdom, 1997-2010; Journal of Royal Society of Medicine. 2014.
Head MG, Fitchett JR, Cooke MK, et al. Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. Journal of Antimicrobial Chemotherapy. 2014.
2014
2013
Fitchett JR, Head MG, Atun R; Infectious disease research investments: Systematic analysis of immunology and vaccine research funding in the UK. Vaccine. 2013.
Head MG, Fitchett JR, Atun R; Global health priorities and research funding Reply, Lancet Infectious Diseases 2013.
Fitchett JR, Head MG, Atun R; The need for more investment in tuberculosis research; Lancet Global Health. 2013.
Head MG, Fitchett JR, Cooke MK, Wurie FB, Atun R. Sex discrepancies in infectious disease research funding 1997—2010: a systematic analysis. The Lancet. 2013.
Head MG, Fitchett JR, Cooke MK, Wurie FB, Atun R; Differences in research funding for women scientists: a comparison analysis of UK investments in global infectious disease research 1997–2010 – BMJ Open 2013.